Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
pharmaphorum5d
Surge of Alzheimer's drugs in pipeline gives hope of progress
Lilly’s solanezumab famously failed to produce significant results in early stage Alzheimer’s late last year, the latest in a long list of drugs that have come up short in trials. George ...
Rolling Out6d
5 ways this cancer drug could revolutionize Alzheimer’s treatment
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
pharmaphorum4d
Older GLP-1 drug shows glimmer of benefit in Alzheimer's
It's possible that Alzheimer's disease could be added to the lengthening list of health conditions that ... stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas ...
STAT11d
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
Ars Technica29d
Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease
One of the most intriguing is a late-stage trial of semaglutide in Alzheimer’s patients ... with the drugs available at a large discount to the list price. Side-effects including nausea ...